Humacyte, INC Form 4 insider transactions

Charles Bruce Green, a director at Humacyte, Inc., executed stock options to acquire 600 shares of common stock at $4.09 on May 17, 2024.

Director Gordon M. Binder reports purchasing 100,000 shares of Humacyte, Inc. common stock through direct and indirect transactions.